Issue Date
2010-06MeSH
Cost-Benefit AnalysisDrug Costs
Economics, Pharmaceutical
Humans
Ireland
Prescription Drugs
Metadata
Show full item recordCitation
Recent developments in pharmacoeconomic evaluation in Ireland. 2010, 10 (3):221-4 Expert Rev Pharmacoecon Outcomes ResJournal
Expert review of pharmacoeconomics & outcomes researchDOI
10.1586/erp.10.33PubMed ID
20545585Language
enISSN
1744-8379ae974a485f413a2113503eed53cd6c53
10.1586/erp.10.33
Scopus Count
Collections
Related articles
- Public drug expenditure in the Republic of Ireland.
- Authors: Barry M, Usher C, Tilson L
- Issue date: 2010 Jun
- Drug expenditure in Ireland 1997-2007.
- Authors: Barry M, Molloy D, Usher C, Tilson L
- Issue date: 2008 Nov-Dec
- Pharmacoeconomic evaluation in Ireland: a review of the process.
- Authors: Tilson L, O'Leary A, Usher C, Barry M
- Issue date: 2010
- Captive markets.
- Authors: Mettner J
- Issue date: 2008 Nov
- Prescription drug costs easier to swallow.
- Issue date: 2010 Apr